LIC MF Healthcare Fund-Direct Plan-Growth

  • Scheme Category:  
  • Equity Scheme >  
  • Sectoral/Thematic Funds
NAV: ₹ 33.0445 ↑ 0.43%
[as on 20 October, 2025]

NAV chart with SMA (Simple moving average) overlay

SMA (Simple Moving Average)

  • 100 SMA
  • 200 SMA
  • 300 SMA
  • 400 SMA
  • 500 SMA

Returns

NameYTD1D1W1M3M1Y3Y5Y7Y10Y
LIC MF Healthcare Fund-Direct Plan-Growth -0.16% 0.43% 1.02% 0.51% 1.23% 1.74%----

Portfolio

Asset allocation

EquityDebtRealestateCommoditiesCash & Equivalents
97.82% 0.00% (Arbitrage: 0.00%) 0.00% 0.00% 2.18%

Equity

NameSectorWeight %
Sun Pharmaceutical Industries Ltd.Pharmaceuticals & Biotechnology10.08%
Apollo Hospitals Enterprise Ltd.Healthcare Services5.85%
Torrent Pharmaceuticals Ltd.Pharmaceuticals & Biotechnology5.55%
Cipla Ltd.Pharmaceuticals & Biotechnology5.51%
Fortis Healthcare Ltd.Healthcare Services4.79%
Piramal Pharma Ltd.Pharmaceuticals & Biotechnology4.45%
Neuland Laboratories Ltd.Pharmaceuticals & Biotechnology4.14%
Divi's Laboratories Ltd.Pharmaceuticals & Biotechnology4.11%
Aurobindo Pharma Ltd.Pharmaceuticals & Biotechnology3.98%
Alkem Laboratories Ltd.Pharmaceuticals & Biotechnology3.96%
Abbott India Ltd.Pharmaceuticals & Biotechnology3.33%
Gland Pharma Ltd.Pharmaceuticals & Biotechnology3.12%
Artemis Medicare Services Ltd.Healthcare Services2.99%
Dr Agarwal's Health Care Ltd.Healthcare Services2.96%
IPCA Laboratories Ltd.Pharmaceuticals & Biotechnology2.88%
Glenmark Pharmaceuticals Ltd.Pharmaceuticals & Biotechnology2.75%
Metropolis Healthcare Ltd.Healthcare Services2.73%
Onesource Specialty Pharma Ltd.Pharmaceuticals & Biotechnology2.61%
Navin Fluorine International Ltd.Chemicals & Petrochemicals2.60%
Mankind Pharma Ltd.Pharmaceuticals & Biotechnology2.45%
Concord Biotech Ltd.Pharmaceuticals & Biotechnology2.39%
Global Health Ltd.Healthcare Services2.31%
Max Healthcare Institute Ltd.Healthcare Services2.19%
Syngene International Ltd.Healthcare Services2.07%
JB Chemicals & Pharmaceuticals Ltd.Pharmaceuticals & Biotechnology1.95%
Vinati Organics Ltd.Chemicals & Petrochemicals1.78%
Anthem Biosciences Ltd.Pharmaceuticals & Biotechnology1.65%
Acutaas Chemicals Ltd.Pharmaceuticals & Biotechnology1.50%
Linde India Ltd.Chemicals & Petrochemicals1.14%
Portfolio data is as on date 30 September, 2025

NAV (Net asset value) history

LIC MF Healthcare Fund-Direct Plan-Growth - 30 days NAV history

DateNAV
20 October, 202533.0445
17 October, 202532.9025
16 October, 202532.7707
15 October, 202532.6147
14 October, 202532.5648
13 October, 202532.7118
10 October, 202532.8027
9 October, 202532.4369
8 October, 202532.2343
7 October, 202532.4027
6 October, 202532.2453
3 October, 202531.898
1 October, 202532.0087
30 September, 202531.7461
29 September, 202531.652
26 September, 202531.5216
25 September, 202532.0372
24 September, 202532.2066
23 September, 202532.394
22 September, 202532.5665
19 September, 202532.8765
18 September, 202532.7764
17 September, 202532.5526
16 September, 202532.5705
15 September, 202532.4946
12 September, 202532.547
11 September, 202532.4734
10 September, 202532.3089
9 September, 202532.131
8 September, 202532.0459

FAQ (Frequently asked questions)

  • What is latest/current NAV/price of LIC MF Healthcare Fund-Direct Plan-Growth?
    The latest NAV of LIC MF Healthcare Fund-Direct Plan-Growth is 33.0445 as on 20 October, 2025.
  • What are YTD (year to date) returns of LIC MF Healthcare Fund-Direct Plan-Growth?
    The YTD (year to date) returns of LIC MF Healthcare Fund-Direct Plan-Growth are -0.16% as on 20 October, 2025.
  • What are 1 year returns of LIC MF Healthcare Fund-Direct Plan-Growth?
    The 1 year returns of LIC MF Healthcare Fund-Direct Plan-Growth are 1.74% as on 20 October, 2025.